Free lookups: 1/3 Unlock Pro
Clinical reference Find a medicine
Ctrl K
1 of 3 free lookups remaining Upgrade
New search Medicine profile Diphenhydramine HCl 6mg + Ammonium Chloride 60mg + Chlorpheniramine Maleate 2mg / 5ml

Clinical medicine profile

Diphenhydramine HCl 6mg + Ammonium Chloride 60mg + Chlorpheniramine Maleate 2mg / 5ml

Therapeutic agent (verify pharmacological class)

POM
Evidence state Source-linked Review date not recorded
Route
See product SmPC
Schedule
POM
ATC
Not assigned
PPB status
registered
Patient advice Check interactions
01 Risk first

Safety essentials

The information most likely to change a prescribing or dispensing decision.

Contraindications

  • [Diphenhydramine] Hypersensitivity to the active substance or excipients.
  • Additional absolute contraindications are indication- and product-specific — consult SmPC. [Ammonium Chloride] [Ammonium chloride] Hypersensitivity to the active substance or excipients.
  • Additional absolute contraindications are indication- and product-specific — consult SmPC. [Chlorpheniramine] Hypersensitivity to the active substance or excipients.
  • Additional absolute contraindications are indication- and product-specific — consult SmPC.

Precautions

  • Warnings Do not use ■ with any other product containing diphenhydramine, even one used on skin ■ to make a child sleepy Ask a doctor before use if the child has ■ glaucoma ■ a breathing problem such as chronic bronchitis
02 Point of care

Dosing matrix

Population and organ-function guidance, shown together for faster comparison.

Adult

Directions ■ if needed, take every 4-6 hours ■ do not take more than 6 doses in 24-hours children under 4 years of age Do not use children 4 to under 6 years of age Do not use unless directed by a doctor children 6 to under 12 years of age 1 to 2 teaspoonfuls (5 ml to 10 ml)

Paediatric

See label paediatric section if present; otherwise use paediatric formulary — do not extrapolate adult doses.

Renal

Review renal impairment dosing; many agents need CrCl/eGFR adjustment.

  • CrCl 0–120: Confirm renal dosing in product SmPC / primary label.
Hepatic

Review hepatic impairment dosing; monitor LFTs if agent is hepatically cleared or hepatotoxic.

03 Clinical use

Use, effects & interactions

Indications

Uses temporarily relieves these symptoms due to hay fever or other respiratory allergies: ■ sneezing ■ itching of the nose or throat ■ runny nose ■ itchy watery eyes ■temporarily relieves these symptoms due to the common cold: ■ sneezing ■ runny nose

Adverse effects

  • [From component Chlorpheniramine] Drowsiness
  • psychomotor impairment
  • anti-muscarinic effects [e.g. urinary retention
  • dry mouth
  • GI disturbances
  • blurred vision]
  • allergic reactions
  • epileptic form seizure in patients with cerebral cortex focal lesion
  • muscle weakness
  • tachycardia
  • tight chest
  • paradoxical CNS stimulation - mostly in children.
  • Fixed-dose/multi-ingredient product.
  • Clinical details partially inherited from component monographs: Chlorpheniramine.
  • Confirm combination SmPC for exact dosing.
04 Pharmacology

Mechanism & disposition

Combination product.

Combination product.Component mechanism (Chlorpheniramine): It…Its anticholinergic actions give a drying…
Read complete mechanism

Combination product. Component mechanism (Chlorpheniramine): It acts by competing with histamine for H1-receptor sites on effector cells. Its anticholinergic actions give a drying effect on the nasal mucosa.

Onset

Product-specific

Duration

Product-specific

Route

See product SmPC

Elimination

are product-specific. Consider food effects, protein binding, hepatic CYP/UGT

Half-life

when adjusting for organ impairment, age and drug interactions. Verify parameters in the current SmPC.

05 Special populations

Pregnancy, lactation & diet

Pregnancy

[Diphenhydramine] Use only if potential benefit justifies potential risk; prefer agents with better reproductive data when alternatives exist. [Ammonium Chloride] [Ammonium chloride] Use only if potential benefit justifies potential risk; prefer agents with better reproductive data when alternatives exist. [Chlorpheniramine] Use only if potential benefit justifies potential risk; prefer agents with better reproductive data when alternatives exist.

Lactation

[Diphenhydramine] Assess infant risk vs benefit of maternal therapy; prefer agents with lactation data. [Ammonium Chloride] [Ammonium chloride] Assess infant risk vs benefit of maternal therapy; prefer agents with lactation data. [Chlorpheniramine] Assess infant risk vs benefit of maternal therapy; prefer agents with lactation data.

06 Kenya market

Brands & loaded prices

FromKES 39
MedianKES 39
Listings1
BrandManufacturerPackObserved price
NICOF DAIMA BIASHARA / Wholesale Import SYRUP 60ML KES 38.70Daima Chemist price-list reference ↗ Source date not recorded · verify current price
07 Provenance

Sources & review state

Primary sourceLocal active-ingredient clinical extract; FDA drug label via OpenFDA/DailyMed; Component monographs (multi-source pipeline); Professional class pharmacology (Therapeutic agent (verify pharmacological class))
Last reviewedNot recorded
EvidenceSource-linked
Open source document ↗

Decision support only. Confirm patient-specific decisions against the current product SmPC, Kenya STG/EML, and professional judgement.